Semin intervent Radiol 2014; 31(04): 370-374
DOI: 10.1055/s-0034-1393974
How I Do It
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Treatment of Infrapopliteal Arterial Occlusive Disease in Critical Limb Ischemia

Brian M. Christenson
1   Eastern Radiological Associates, Billings, Montana
,
Paul Rochon
2   Department of Radiology, University of Colorado, Aurora, Colorado
,
Matthew Gipson
2   Department of Radiology, University of Colorado, Aurora, Colorado
,
Rajan Gupta
2   Department of Radiology, University of Colorado, Aurora, Colorado
,
Mitchell T. Smith
2   Department of Radiology, University of Colorado, Aurora, Colorado
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
14. November 2014 (online)

Infrapopliteal Arterial Occlusive Disease

There is increasing evidence supporting endovascular intervention in patients with critical limb ischemia (CLI) and infrapopliteal artery occlusion where in-line flow to the foot can be reestablished. Patients with CLI due to infrapopliteal arterial occlusive disease are a high-risk group in which the current reported amputation and mortality rates at 1 year are 25% and 20 to 25%, respectively.[1] [2] Treatment of infrapopliteal arterial disease is vital to prevent amputation, relieve ischemic pain, heal lower extremity wounds, and prevent gangrene.

Technical success rates are often high (approaching 90%) in infrapopliteal angioplasty, with associated clinical success of approximately 70% in some larger series of patients with CLI.[3] Predictors of a successful outcome include a short occlusion length and minimal vessels or stenoses needing treatment. The updated Trans-Atlantic Inter Society Consensus (TASC)–II guidelines concluded that there is increasing evidence to support the recommendation for angioplasty in patient with CLI and infrapopliteal artery occlusion; lesion length alone is no longer used to determine a recommendation for treatment (as was seen with the TASC-1 guidelines).[1] The following procedure describes our approach to treating infrapopliteal arterial occlusive disease.

 
  • References

  • 1 Norgren L, Hiatt WR, Dormandy JA , et al; TASC II Working Group. Inter-Society Consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 01) S1-S75
  • 2 Hirsch AT, Haskal ZJ, Hertzer NR. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extermity, renal, mesenteric, and abdominal aortic): executive summary: a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 2006; 47: 1239-1312
  • 3 Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47 (5) 975-981
  • 4 Spinosa DJ, Harthun NL, Bissonette EA , et al. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) for subintimal recanalization to treat chronic critical limb ischemia. J Vasc Interv Radiol 2005; 16 (1) 37-44
  • 5 Martens JM, Knippenberg B, Vos JA, de Vries JP, Hansen BE, van Overhagen H. PADI Trial Group. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J Vasc Surg 2009; 50 (3) 687-689
  • 6 Giles KA, Pomposelli FB, Hamdan AD , et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 2008; 48 (1) 128-136
  • 7 Söderström M, Arvela E, Korhonen M , et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies for critical limb ischemia:. a propensity score analysis. Ann Surg 2010; 252: 765-773
  • 8 Schmidt A, Piorkowski M, Werner M , et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011; 58 (11) 1105-1109
  • 9 Brodmann M, Froehlich H, Dorr A , et al. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia. Vasa 2011; 40 (6) 482-490
  • 10 Rand T, Lammer J, Rabbia C , et al. Percutaneous transluminal angioplasty versus turbo static carbon-coated stents in infrapopliteal arteries: InPeria II trial. Radiology 2011; 261 (2) 634-642
  • 11 Donas KP, Torsello G, Schwindt A, Schönefeld E, Boldt O, Pitoulias GA. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg 2010; 52 (2) 356-361
  • 12 Rastan A, Tepe G, Krankenberg H , et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J 2011; 32 (18) 2274-2281